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#Senior epidemiologist.CopyrObjective: To examine yield and costs of two screening methods for depressive symptoms in subjects
75 years in general practice.
Methods: In 73 general practices of 12.144 registered subjects 75 years 10.681 could be invited for
screening. In the first 31 practices we invited 3797 subjects for direct screening which implied an invitation
by letter followed by a home visit to administer the 15-item Geriatric Depression Scale (GDS-15). In the
remaining 42 practices 6884 subjects were invited for stepped screening which implied that the GDS-15
was sent by post, followed by a home visit only if the self-administered GDS-15-score was  4 points.
Being screen-positive for depressive symptoms was defined as an interviewer-administered GDS-15-
score 5 points. Screening costs were estimated based on results in this study.
Results:Of all registered subjects 707 (5.8%) were already being treated for depression. The yield of direct
screening was higher than of stepped screening (2.6% versus 1.9%, p¼ 0.009), with similar yields for
subjects aged 75–79 years and for subjects aged 80 years. In a standard GP-practice with 160 subjects
75 years estimated total screening costs are about twice as high for direct screening than for stepped
screening. Estimated costs per screen positive subject are s350 for direct screening and s250 for stepped
screening.
Conclusion: Direct screening has a higher yield, but is also more time consuming and more expensive.
Whether the extra yield is clinically relevant and worth the extra costs, will depend on the subsequent
treatment effect.
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230 G. M. van der Weele et al.Introduction
Depressive symptoms are common in older people and
have a negative impact on quality of life (Unutzer
et al., 2000a), daily functioning (Beekman et al., 1997;
Chopra et al., 2005; Lyness et al., 2007), health service
utilization (Beekman et al., 2002), and mortality
(Penninx et al., 1999; Cuijpers and Smit, 2002; Stek
et al., 2005). Furthermore older people with depressive
symptoms have an elevated risk to develop major
depression (Lyness et al., 2006; Schoevers et al., 2006;
Stek et al., 2006). Although depression has been
reported to be preventable (van ’t Veer-Tazelaar et al.,
2009), most older people with depressive symptoms do
not receive available adequate treatment (Unutzer
et al., 2000b; Wilson et al., 2001; Bijl et al., 2004; Van
Citters and Bartels, 2004; Skultety and Zeiss, 2006;
Cuijpers et al., 2007; Steinman et al., 2007). Under-
treatment of depressive symptoms in older people may
partly be due to poor recognition because of somatic
co-morbidity and because older people, their family
and their general practitioners (GP) easily regard
depressive symptoms as normal in the process of aging
(Crawford et al., 1998; Volkers et al., 2004; Murray
et al., 2006). To enhance case detection, screening for
depressive symptoms is recommended, if treatment
is available for screen-positive subjects (Valenstein
et al., 2001; Pignone et al., 2002). However, the
advisability of screening programs is still debated
because evidence on the effectiveness of screening
programs for depression is inconclusive. Some large
trials showed positive results with respect to depressive
symptoms among intervention patients who were
(partly) detected by screening (Unutzer et al., 2002;
Bruce et al., 2004), whereas other trials found no
positive effects (Callahan et al., 1994; Whooley et al.,
2000).
In research settings, different screening approaches
have been used such as depression screening integrated
in comprehensive health checks (Arthur et al., 2002;
Osborn et al., 2002; van ’t Veer-Tazelaar et al., 2008)
versus screening for depression only (Licht-Strunk
et al., 2005), screening all subjects registered in a
general practice (van ’t Veer-Tazelaar et al., 2008)
versus screening attendees only (Licht-Strunk et al.,
2005; Weyerer et al., 2008), and interviewing all
responders (Arthur et al., 2002; Osborn et al.,
2002; Luppa et al., 2008) versus two-stepped
screening in which subjects are interviewed only after
screening positive on a self-administered questionnaire
(Licht-Strunk et al., 2005). Since in the Netherlands
everyone has a GP, systematic screening of all
community dwelling older people is suitable.Copyright # 2010 John Wiley & Sons, Ltd.In order to enhance implementation in daily
practice, evidence based information is needed about
both screening and treatment of screen-positive
subjects. Especially for the oldest old there is not
enough information about the yield of screening in
relation to the costs. Therefore, we studied the
differences in yield and costs of two methods of
screening for the broad spectrum of depressive
symptoms in all subjects aged 75 years and over
who were registered in general practice, thereby also
including those who (almost) never visit their GP.
Firstly, we chose a screening method that theoretically
would ensure the highest yield by visiting all
participants at their own home. Secondly, we chose
a less labor intensive and time consuming method, in
which not all participants had to be visited. We
hypothesized that the more intensive, costly screening
method would result in a higher yield, especially
among the oldest old.
Consequently, our research questions were ‘What
are the differences in yield and costs of two methods of
screening for untreated depressive symptoms in
subjects aged 75 years and over in general practice;
and do costs and yield differ between subjects aged
75–79 years and subjects  80 years?’Methods
Study population and procedures
This screening study is part of the PROMODE study
(PROactive Management Of Depression in the Elderly)
and was followed by a pragmatic, cluster-randomised,
controlled trial. The Medical Ethical Committee of the
Leiden University Medical Center approved of the
study.
We invited all GP practices with at least 80 registered
subjects aged  75 years in the Leiden region, the
Netherlands (n¼ 113): 73 practices (65%) consented
to participate and 40 (35%) not. The study population
consisted of all subjects aged  75 years, registered in
the 73 participating practices. Exclusion criteria were
current treatment for depression (psychological and/
or use of antidepressants), a clinical diagnosis of
dementia or a Mini-Mental State Examination-score
(MMSE)< 19 points (Folstein et al., 1975), loss of
partner or child in the preceding 3 months, terminal
illness with a life expectancy <3 months and not
speaking Dutch.
From April 2007 to July 2008, subjects were invited
to participate (see flow chart, figure 1). For direct
screening, all subjects in the first 31 consecutiveInt J Geriatr Psychiatry 2011; 26: 229–238.
Screening for depressive symptoms in subjects 75 years 231practices were invited to participate by sending them a
study information leaflet and a response card for
agreement to be contacted for a home visit. After
2–3 weeks non-responders were phoned to ask for
participation. Trained research nurses visited all
subjects who agreed for an interview. For stepped
screening, in the remaining 42 consecutive practices we
sent the 15-item Geriatric Depression Scale (GDS-15)
by post, with a postal reminder after 2–3 weeks.
Subjects who scored 4 points on the self-adminis-
tered GDS-15 were visited for an interview by a
research nurse. In order to get an indication of false
negatives, all subjects with a self-administered GDS-
15-score <4 of the first practice receiving stepped
screening were also interviewed. Of 72 subjects only 1
had an interviewer-administered GDS-15-score 5
(negative predictive value¼ 0.98). In all interviews the
MMSE and GDS-15 were administered. In screen-
positives (interviewer-administered GDS-15 scores 5
points), we administered also the Montgomery Åsberg
Depression Rating Scale (MADRS) for assessment of
severity of depression and the Mini-International
Neuropsychiatric Interview (MINI) for assessment of
DSM-IV diagnoses of depression.Measurements
The GDS-15, used as screening instrument, has been
developed to screen for depression in older popu-
lations (Sheikh and Yesavage, 1986). In a recent meta-
analysis (based on 69 studies) of the diagnostic
accuracy, clinical utility and added value of the
GDS-15 in primary care, the GDS-15 was rated ‘good’
for screening (Mitchell et al., 2009). It ranges from 0 to
15 points, with higher scores indicating more
depressive symptoms. We considered an interviewer-
administered GDS-score  5 points as screen-positive,
because we chose to include the broad depressive
spectrum, ranging from symptoms not meeting formal
DSM-IV diagnostic criteria for depression to major
depression. The cut-off score of 5 points that we used
to define being screen-positive provides good sensi-
tivity and specificity in primary care settings (D’Ath
et al., 1994; De Craen et al., 2003).
Although diagnosing depressive disorders was not
the focus of this study, we were interested whether both
methods yielded screen-positive subjects with similar
presence of a depressive disorder according to formal
DSM-IV-criteria and similar severity of depression. To
assess whether screen-positive subjects had a depressive
disorder according to formal DSM-IV-criteria, includ-
ing minor and major depression and dysthymia, weCopyright # 2010 John Wiley & Sons, Ltd.used the MINI (Sheehan et al., 1998). To assess the
severity of depression among screen-positive subjects
we used the MADRS. The MADRS is an interviewer-
rated scale that can be administered by trained nurses.
The MADRS consists of 10 items ranging from 0–6
points, resulting in possible total scores of 0–60 points.
Higher scores indicate more severe depression.
To assess possible differences in presence of
depressive symptoms between participants and non-
participants in the screening program, GPs were asked
to give their clinical judgment for each invited subject
about the presence of depressive symptoms, before
inclusion started. The possible answers were ‘present,
possibly present, absent, or unknown’.Training of research nurses
Training of nurses occurred on a regular basis. The
nurses were instructed how to use the different
questionnaires in a uniform way, with special attention
to the GDS and MADRS. For the GDS, which has a yes/
no-answering format with very strict standard ques-
tions, training concentrated mainly on the use of
the exact phrasing of questions. With respect to the
MADRS all interviews were videotaped. These tapes
were used for both training and inter-rater agreement.
If no initial agreement existed discussion followed to
reach consensus.Statistical analysis
The yield and costs of the two different screening
methods were compared within subjects aged 75–79
years and subjects aged 80 years and for both sexes,
separately. Data are presented in absolute numbers
with percentages and in medians with interquartile
ranges (IQR). Categorical data were analyzed using x2
test and continuous data using Mann–Whitney U-test.
Statistical analyses were carried out using the SPSS 16.0
for Windows.Economic evaluation
We calculated expected costs if screening would be
implemented in a standard Dutch general practice with
160 subjects  75 years (80 subjects aged 75–79 years
and 80 subjects aged 80 years) given the exclusion
rate, participation rate and screening yield found in
our study, with the additional assumption that 20%
of interviews needs to be done at home in subjectsInt J Geriatr Psychiatry 2011; 26: 229–238.
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investment for the different procedures was estimated
on experience in our study. We used the 2009 Dutch
tariffs for the staff members in general practice who
would be involved, including administrative pro-
cedures by the practice assistant (PA) and adminis-
tration of GDS-15 by a practice nurse (PN)
(www.NVDA.nl, 2009; www.Nza.nl, 2009).Results
Study population
Of all subjects aged 75 years and over who were
registered in the participating practices, 1463 subjects
(12%) were excluded by their GPs (Figure 1), mostly
because of current depression treatment (n¼ 707) or a
clinical diagnosis of dementia or MMSE< 19 pointsFigure 1 Flow chart screening (numbers of subjects and % of registered subje
Copyright # 2010 John Wiley & Sons, Ltd.(n¼ 631). For direct screening, 3797 subjects were
invited, of whom 166 (4%) were excluded after
invitation (49 before the interview took placeþ 117
during baseline interviews). Of the remaining subjects
54% (1965/3631) participated. For stepped screening,
6884 subjects were invited, of whom 140 (2%) were
excluded after invitation (78 before the interview took
placeþ 62 during baseline interviews). Of the remain-
ing subjects 50% (3365/6744) participated.
The percentage of subjects aged 80 years in direct
screening was somewhat higher than in stepped
screening (56% versus 52%, p< 0.001) (Table 1). In
direct screening the prevalence of exclusion criteria was
higher than in stepped screening (17% versus 13%,
p< 0.001), mainly due to a higher percentage of ‘other
exclusion criteria’, such as not speaking Dutch.
Populations in both screening methods did not differ
regarding to sex, exclusion for current depression
treatment and clinical diagnosis of dementia and GP’scts).
Int J Geriatr Psychiatry 2011; 26: 229–238.






n % n %
Age
75–79 years 1937 (44) 3711 (48) < 0.001
 80 years 2431 (56) 4065 (52)
Sex
Female 2729 (63) 4780 (62) 0.27
Male 1639 (38) 2996 (39)
Exclusion criteria present 737 (17) 1032 (13) < 0.001
Current depression treatment 282 (6.5) 425 (5.5) 0.32
Clinical diagnosis of dementia /MMSE< 19 235 (5.4) 396 (5.1)
GP-judgment ‘(possibly) depressed’ without exclusion 785 (18) 1195 (17) 0.33
Screening for depressive symptoms in subjects 75 years 233clinical judgment of depression, also if data were
analyzed for both age groups separately (data not
shown).Yield of screen-positives
In the total sample of registered subjects, the yield of
direct screening was higher than of stepped screening
(2.6% (115/4368) versus 1.9% (149/7776), p¼ 0.009),
without difference between age groups (Table 2).
Analyses at the GP-level also gave higher yields of direct
screening compared to stepped screening (2.7% (range
0–5%) versus 1.8% (range 0–4%), p¼ 0.003). The
yield of direct and stepped screening was similar
for men (1.9% versus 1.6%, p¼ 0.51). For women
however, the yield of direct screening was higher than
the yield of stepped screening (3.1% versus 2.1%,
p¼ 0.009). This was seen in both age groups, but was
most clear in the age group  80 years (data not
shown).Table 2 Yield of screen-positive subjects (GDS-15 5) per screening






Yielda % Yielda %
Age
75–79 years 51/1937 (2.6) 69/3711 (1.9) 0.056
 80 years 64/2431 (2.6) 80/4065 (2.0) 0.078
Sex
Male 30/1639 (1.9) 47/2996 (1.6) 0.51
Female 85/2729 (3.1) 102/4780 (2.1) 0.009
Total 115/4368 (2.6) 149/7776 (1.9) 0.009
GDS-15¼Geriatric Depression Scale 15-items version.
aYield: screen positive subjects per (sub)group.
Copyright # 2010 John Wiley & Sons, Ltd.Comparison between participants and non-
participants
In Table 3, participants and non-participants are
compared according to sex and GP clinical judgment
on the presence of depression for both age groups and
screening methods separately. In direct screening, for
both age groups there was no difference in sex
distribution. In stepped screening however, in both age
groups participants compared to non-participants
were less likely to be women. According to GP clinical
judgment of depression, in direct screening partici-
pants compared to non-participants were less likely to
be judged as depressed or possibly depressed. In
stepped screening this was also seen in the age group
80 years, but not in the age group 75–79 years
(Table 3).Characteristics of screen-positive subjects
To explore if screen-positive subjects in both screening
methods had similar characteristics, we could evaluate
data of 239 subjects. Of all 264 screen-positive subjects
239 agreed to additional assessment of depression
diagnosis and severity; in direct screening 13 subjects
could not be further assessed (2 dropped out, 11
refused) and in stepped screening 12 subjects
(2 dropped out, 10 refused). Screen-positive subjects
did not differ between screening methods with respect
to demographic characteristics, including age, sex and
living alone. Severity of depressive symptoms and
presence of DSM-IV depression diagnoses were also
similar. Median MADRS-score was 13 points in both
groups. In direct screening a DSM-IV diagnosis was
present in 41% of screen-positive subjects, in stepped
screening this was 46% (p¼ 0.46).Int J Geriatr Psychiatry 2011; 26: 229–238.
Table 3 Participants and non-participants of both screening methods (n¼ 10375a)






n % n % n % n %
75–79 years
Sex
Male 403 (44) 331 (43) 0.77 888 (50) 593 (38) <0.001
Female 512 (56) 433 (57) 900 (50) 952 (62)
GP clinical judgment
(Possibly) depressed 164 (18) 181 (24) 0.004 319 (18) 288 (19) 0.55
Not depressedb 751 (82) 583 (76) 1469 (82) 1257 (81)
Total 915 764 1788 1545
80 years
Sex
Male 390 (37) 310 (34) 0.20 626 (40) 564 (31) <0.001
Female 660 (63) 592 (66) 951 (60) 1270 (69)
GP clinical judgment
(Possibly) depressed 200 (19) 240 (27) <0.001 254 (16) 358 (20) 0.010
Not depressedb 850 (81) 662 (73) 1323 (84) 1476 (81)
Total 1050 902 1577 1834
aall registered subjects (n¼12144) minus excluded subjects (n¼1769).
bnot depressed, including judgment ‘unknown’ or missing.
234 G. M. van der Weele et al.Estimated costs and cost effectiveness of both
screening methods
Table 4 shows the estimated costs of both screening
methods if screening would be implemented in a
standard GP-practice with 80 subjects 75–79 years and
80 subjects 80 years. Compared to stepped screening,
per standard practice total costs of direct screening
would be about twice as high (75–79 years s745 versus
s374, 80 years s764 versuss349, total s1509 versus
s723), since the number of contacts for interviews
was much higher in direct screening. Estimated costs
per screen-positive subject were also higher for direct
screening than for stepped screening, about s350
versus s250 (75–79 years s346 versus s249,
80 years s349 versus s224). With direct screening
0.7% additional screen-positives were found for s569
per additional screen-positive in the age group 75–
79 years and s659 in the age group 80 years.Discussion
In our study the yield of screening for untreated
depressive symptoms among all registered subjects
aged 75 years and over in general practice was 2.2%,
with a somewhat higher yield in direct screening thanCopyright # 2010 John Wiley & Sons, Ltd.in stepped screening. With direct screening total
screening costs and costs per registered subject are
about twice as high as with stepped screening.
In this paper the yield of screening was defined as the
percentage of registered subjects that screened positive.
In general, interpretation of the magnitude of
differences in yield cannot be separated from whether
subjects will subsequently agree to undergo treatment
and whether treatment will be beneficial. For instance,
when all detected subjects will benefit from treatment,
even a 1% difference in yield may be regarded as
clinically relevant. When only 10% of detected subjects
will benefit from treatment, a 1% difference in yield is
not likely to be clinically relevant. The yield of both
screening and treatment together will determine the
clinical relevance of the screening method. Our paper
gives information on the crucial first step in this
process. Regarding treatment effects among screen-
positive depressive subjects, both positive and negative
results have been reported. Cuijpers et al. recently
published a review of trials that examined the effects of
psychological treatment; studies with extra elements
(like managed care interventions or disease manage-
ment programs) were excluded. They concluded that
psychological treatment of depression has little effect
when patients are recruited through systematic screen-
ing (as opposed to patients who are referred forInt J Geriatr Psychiatry 2011; 26: 229–238.
Table 4 Estimated costs of direct and stepped screening per age group in a standard GP-practice with 80 subjects 75-79 years and 80 subjects  80 years




















a. Basic costsb 80 249 80 285 80 235 80 268
Number of subjects invited 71.2 71.2 66.4 66.4
b. Scoring self-administered GDS 1PA — — 38.4 17 — — 30.5 14
c. Making interview appointment 3PA 38.4 52 4.2 6 35.9 48 3.4 5
d. Interviewc
-in GP-practice 15PN 30.8 277 3.4 30 21.5 194 2.0 18
-at home 30PN 7.7 138 0.8 15 14.3 258 1.3 24
e. Evaluation screen-positive result 5 PNþGP 2.2 16 1.5 11 2.2 16 1.6 12
f. Exchange results with patient 10PN 2.2 13 1.5 9 2.2 13 1.6 9
Total costs per practice 745 374 764 349
Costs per registered subject 9 5 10 5
Costs per screen positive 346 249 349 224
Costs per additional screen
positive (direct versus stepped
screening)
569 659
GDS¼Geriatric Depression Scale, 15-item-version.
Estimated costs¼ staff time in minutes times amount in s per minute staff time times number of subjects left (n).
aPA¼Practice Assistant s0.45 per minute; PN¼ Practice Nurse s0.60 per minute; GP¼General Practitioner s0.90 per minute.
bBasic costs, based on observed exclusion and response rates, include: material costs and staff time for extraction electronic patient list by PA, check for
exclusion criteria by GP, invitation by post and reminder (per telephone or postal) by PA
cassumption: in group 75–79 years 20% of screening interviews have to be performed at home and in group 80 years 40%.
Screening for depressive symptoms in subjects 75 years 235treatment by their GP) (Cuijpers et al., 2009).
However, encouraging results were found in the
PROSPECT trial, in which care management that
was offered to screen-positive subjects 60 years
reduced suicidal ideation (Bruce et al., 2004), and in a
recent Dutch trial, in which stepped care offered to
screen-positive subjects 75 years reduced the risk to
develop a depressive or anxiety disorder (van ’t Veer-
Tazelaar et al., 2009).
Our overall yield of 2% is lower than the 7–36%
reported in earlier screening studies (Koenig and
Blazer, 1992). Two very similar studies, that also
screened subjects aged 75 years in general practice for
depressive symptoms defined as a GDS-15 score 5
points, showed yields of 8% (Arthur et al., 2002) and
13% (Osborn et al., 2002). However, in contrast to
these studies, we excluded 6% of all registered subjects
because they already received depression treatment.
Taking this into account, our yield is in line with earlier
findings.
Participation in direct and stepped screening was
very similar (54% and 50%, respectively). Apparently a
more labor-intensive approach does not guarantee
higher response rates. Beforehand we had no hypoth-Copyright # 2010 John Wiley & Sons, Ltd.esis on gender differences. We found that participation
among women was higher in direct screening than in
stepped screening. Among men we found no difference
in yield of screen-positives between the two screening
methods. Among women the yield of screen-positives
was 1% higher in direct screening than in stepped
screening, but again the clinical relevance of this
finding can be debated.
Costs of screening differed with total number and
participation rate of subjects, the payment of the
screening staff member and the number of subjects to
be visited at home. Costs differ mostly with the number
of subjects to be interviewed, which is related to the
screening method. Compared to direct screening, pre-
screening by self-administered GDS-15, possibly
followed by a phone call to non-responders for
assessment of GDS, will reduce costs. Further
reduction in costs might be possible by integrating
screening in routine clinical practice, since most older
people have several contacts every year with their GP.
However, implementation of pro-active case finding
during regular contacts often proved to be difficult in
Dutch general practice (www.nationaalkompas.nl,
2009).Int J Geriatr Psychiatry 2011; 26: 229–238.
236 G. M. van der Weele et al.A major strength of this study is the comparison of
yield and costs of two different screening methods for
untreated depressive symptoms in a large number of
subjects aged 75 years and over. In addition, this study
gives insight in the (un)willingness of older people to
participate in screening for depressive symptoms
depending on method of invitation, age, and sex.
Our findings can help in making decisions how
screening for depressive symptoms in older age groups
should be done. Because there is increasing evidence
that treatment of depressive symptoms in late life can
have important positive effects, such as preventing the
onset of major depression (van ’t Veer-Tazelaar et al.,
2009), we screened for depressive symptoms rather
than depressive disorders. A next step to investigate
should be whether people with depressive symptoms
who are detected by screening gain as much from
(preventive) interventions as people who present
themselves with symptoms.
It could be seen as a limitation that practices were
not randomized. Over a period of 14 months all GP
practices, with at least 80 registered subjects aged 75
years, in the Leiden region were invited to participate.
No other selection criteria were used. In the first 31
practices that were included direct screening was
performed and in the next 42 practices stepped
screening. During the recruitment period rates and
reasons to refuse participation did not change; the
reasons that were mentioned were lack of time and
being engaged in practice reorganization or in other
research projects. Because of the unselective recruit-
ment combined with the high number of participating
practices, we had no reason to believe that practice
characteristics differ between both screening methods
regarding to prevalence of depressive symptoms in
their population and the patients’ willingness to be
screened. Furthermore, our findings that the popu-
lations in both screening methods did not differ
regarding current depression treatment and GP’s
clinical judgment of depression did not raise suspicion
that GPs in both methods differed in recognizing and
treating depression at high age.
In our study the response rates were 50–54%. Low
response rates combined with high exclusion rates
could compromise the validity and generalizability of
results in a prevalence study. This is, however, not the
case for our pragmatic study, in which we assessed the
differences in yield and costs as outcome measures for
the two different screening strategies. Similarly,
differences between participants and non-participants
do not undermine our results, but show characteristics
of the particular screening strategies. Because selective
non-response of depressed subjects could undermineCopyright # 2010 John Wiley & Sons, Ltd.cost-effective screening we were especially interested
whether non-responders were more frequently judged
as depressed by their GP compared to responders.
Mainly in direct screening, we found that subjects who
were judged by their GP as depressed or possibly
depressed participated less frequently than subjects
who were not depressed. This suggests that a more
intensive approach does not necessarily attract those
subjects the GPs most worry about. Despite this, the
yield of direct screening was higher. We hypothesize
that non-responders could be the ones less likely to
accept an unsolicited treatment offer.
In stepped screening we introduced self-adminis-
tration of the GDS, but being screen-positive was still
based on the interviewer-administered GDS. O’Neill et
al. found that self-administered GDS-scores are
generally higher than interviewer-rated scores of the
same person (O’Neill et al., 1992). Therefore, not
visiting subjects with a self-administered GDS-
score< 4 points seems acceptable. Even if some of
the GDS-scores would be incorrect, this still would not
invalidate our pragmatic comparison of the two
screening strategies. Self-administration of the GDS
also introduces the possibility that a proxy fills out the
form. We expect that subjects with visual impairment
or illiteracy would have needed help from a proxy to be
able to participate in screening. Problems could arise
when a proxy fills in the GDS-form without consulting
the person who was intended to be screened, but filling
out depression questionnaires by a proxy generally
results in higher scores compared to self-administered
scores (Brown and Schinka, 2005; Nitcher et al., 2009).
In conclusion, our study shows that direct screening
of all registered subjects aged 75 years and over in a GP-
practice for untreated depressive symptoms has a
higher yield than stepped screening. However, total
screening costs per practice of direct screening are
twice as high as total costs of stepped screening.
Whether the extra yield is clinically relevant and worth
the extra costs will depend on the subsequent
treatment effect.Conflict of interest
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Key Points
 In this study the yield of screening for untreated
depressive symptoms among all registered sub-
jects aged 75 years and over in general practice was
2.2%.
 Direct screening has a higher yield than stepped
screening, but costs are about twice as high for
direct screening.
 Whether the extra yield is clinically relevant and
worth the extra costs, will depend on the
subsequent treatment effect.
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